Published in Metabolism on November 01, 2007
Fenofibrate and metabolic syndrome. Endocr Metab Immune Disord Drug Targets (2010) 1.01
Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor. Br J Pharmacol (2008) 0.82
Association of RXR-Gamma Gene Variants with Familial Combined Hyperlipidemia: Genotype and Haplotype Analysis. J Lipids (2013) 0.79
Renal damage in primary aldosteronism: results of the PAPY Study. Hypertension (2006) 4.20
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol (2006) 3.74
Oxidative stress in patients affected by primary aldosteronism. J Hypertens (2014) 3.34
Prevalence, clinical, and molecular correlates of KCNJ5 mutations in primary aldosteronism. Hypertension (2012) 2.31
Non-alcoholic fatty liver syndrome: a hepatic consequence of common metabolic diseases. J Gastroenterol Hepatol (2003) 2.30
Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or nonfunctional paragangliomas. J Clin Endocrinol Metab (2009) 1.53
The aldosterone-renin ratio based on the plasma renin activity and the direct renin assay for diagnosing aldosterone-producing adenoma. J Hypertens (2010) 1.46
Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients. J Hepatol (2011) 1.46
Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism. Hypertension (2009) 1.45
The functional HERG variant 897T is associated with Conn's adenoma. J Hypertens (2006) 1.41
A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke. JAMA (2004) 1.40
Body mass index predicts plasma aldosterone concentrations in overweight-obese primary hypertensive patients. J Clin Endocrinol Metab (2008) 1.38
Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteria. Liver Transpl (2015) 1.38
Water, mineral waters and health. Clin Nutr (2005) 1.37
Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology (2012) 1.34
Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects. Arch Dermatol Res (2010) 1.30
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. Arterioscler Thromb Vasc Biol (2005) 1.19
Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma. Hypertension (2007) 1.13
Angptl3 deficiency is associated with increased insulin sensitivity, lipoprotein lipase activity, and decreased serum free fatty acids. Arterioscler Thromb Vasc Biol (2013) 1.11
Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy. Free Radic Biol Med (2006) 1.08
Gastrointestinal and retroperitoneal manifestations of type 1 neurofibromatosis. J Gastrointest Surg (2010) 1.05
Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects. Osteoporos Int (2004) 1.03
Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization. J Clin Endocrinol Metab (2012) 1.03
Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. J Clin Endocrinol Metab (2007) 1.02
Treating statin-intolerant patients. Diabetes Metab Syndr Obes (2011) 1.01
Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease. Haematologica (2003) 0.98
Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J Hypertens (2007) 0.96
Adipokines and cardiometabolic profile in primary hyperaldosteronism. J Clin Endocrinol Metab (2010) 0.95
Surgical management of abdominal manifestations of type 1 neurofibromatosis: experience of a single center. Am Surg (2010) 0.93
Multiple catecholamine-secreting paragangliomas: diagnosis after hemorrhagic stroke in a young woman. Endocr Pract (2008) 0.92
Usefulness of atherogenic dyslipidemia for predicting cardiovascular risk in patients with angiographically defined coronary artery disease. Am J Cardiol (2007) 0.90
Erectile dysfunction in systemic sclerosis: effects of longterm inhibition of phosphodiesterase type-5 on erectile function and plasma endothelin-1 levels. J Rheumatol (2007) 0.88
Thyroid cancer in patients with hyperthyroidism. Horm Res (2003) 0.87
99mTc-EDDA/HYNIC-TOC in the management of medullary thyroid carcinoma. Cancer Biother Radiopharm (2004) 0.86
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. J Lipid Res (2013) 0.86
von Hippel Lindau disease with colon adenocarcinoma, renal cell carcinoma and adrenal pheochromocytoma. Intern Med (2013) 0.85
Mechanisms of diabetic dyslipidemia: relevance for atherogenesis. Curr Vasc Pharmacol (2012) 0.85
Epicardial fat thickness and left ventricular mass in subjects with adrenal incidentaloma. Endocrine (2013) 0.85
Hypovitaminosis D is independently associated with metabolic syndrome in obese patients. PLoS One (2013) 0.85
Regulation by hypoxia of adrenomedullin output and expression in human trophoblast cells. Eur J Obstet Gynecol Reprod Biol (2010) 0.84
C242T polymorphism of NADPH oxidase p22phox and recurrence of cardiovascular events in coronary artery disease. Arterioscler Thromb Vasc Biol (2008) 0.84
Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence. Antimicrob Agents Chemother (2012) 0.83
High plasma levels of human chromogranin A and adrenomedullin in patients with pheochromocytoma. Tumori (2005) 0.83
KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism. J Hypertens (2014) 0.83
Epicardial fat thickness and nonalcoholic fatty liver disease in obese subjects. Obesity (Silver Spring) (2013) 0.83
Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation. Liver Transpl (2010) 0.82
Posttransplantation hepatitis E: transfusion-transmitted hepatitis rising from the ashes. Transplantation (2013) 0.82
Adrenomedullin in perinatal medicine. Regul Pept (2003) 0.82
A spontaneous, double-blind, double-dummy cross-over study on the effects of daily vardenafil on arterial stiffness in patients with vasculogenic erectile dysfunction. Int J Cardiol (2011) 0.81
Increased risk of cardiac death in primary hyperparathyroidism: what is a role of electrical instability? Int J Cardiol (2006) 0.81
Somatic mutations in the KCNJ5 gene raise the lateralization index: implications for the diagnosis of primary aldosteronism by adrenal vein sampling. J Clin Endocrinol Metab (2012) 0.81
Detection of familial hypercholesterolemia in a cohort of children with hypercholesterolemia: results of a family and DNA-based screening. Atherosclerosis (2006) 0.80
Role of growth factors on human parathyroid adenoma cell proliferation. World J Surg (2010) 0.80
Intracoronary adiponectin levels rapidly and significantly increase after coronary revascularization. Int J Cardiol (2009) 0.80
Clinical experience with pheochromocytoma in a single centre over 16 years. High Blood Press Cardiovasc Prev (2013) 0.80
Pigmented 'black' cardiac paraganglioma in a patient with a novel germ-line SDHD mutation. Eur J Cardiothorac Surg (2008) 0.80
Primary aldosteronism in a patient who exhibited heart failure. J Clin Hypertens (Greenwich) (2012) 0.79
Subclinical atherosclerosis in systemic lupus erythematosus and antiphospholipid syndrome: focus on β2GPI-specific T cell response. Arterioscler Thromb Vasc Biol (2014) 0.79
Venous endotelin-1 (ET-1) and brain natriuretic peptide (BNP) plasma levels during 6-month bosentan treatment for pulmonary arterial hypertension. Regul Pept (2008) 0.79
Effects of prenatal betamethasone administration on leptin and adiponectin concentrations in maternal and fetal circulation. Am J Obstet Gynecol (2008) 0.79
Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia. Atherosclerosis (2010) 0.79
Functional rs20417 SNP (-765G>C) of cyclooxygenase-2 gene does not predict the risk of recurrence of ischemic events in coronary patients: results of a 7-year prospective study. Cardiology (2010) 0.79
Severe coronary and extracoronary atherosclerosis in autosomal recessive hypercholesterolemia detected by whole-body computed tomography angiography. Intern Emerg Med (2011) 0.79
Association of RXR-Gamma Gene Variants with Familial Combined Hyperlipidemia: Genotype and Haplotype Analysis. J Lipids (2013) 0.79
Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism. Metabolism (2007) 0.78
Adrenomedullin and nitric oxide synthase at the maternal-decidual interface in early spontaneous abortion. J Reprod Med (2004) 0.78
Bone mineral metabolism in patients with neurofibromatosis type 1 (von Recklingausen disease). Arch Dermatol Res (2011) 0.78
Intrafollicular concentration of adrenomedullin is associated with IVF outcome. Gynecol Endocrinol (2010) 0.78
Adrenomedullin in human male reproductive system. Eur J Obstet Gynecol Reprod Biol (2005) 0.78
Changes in the interrelationship between leptin, resistin and adiponectin in early neonatal life. Front Biosci (Elite Ed) (2010) 0.77
Aldosterone-induced oxidative stress: a potential mechanism of aldosterone autonomy in primary aldosteronism. J Hypertens (2014) 0.77
Primary aldosteronism with concurrent primary hyperparathyroidism in a patient with arrhythmic disorders. Intern Med (2013) 0.77
Follicular fluid adrenomedullin concentrations in spontaneous and stimulated cycles: relationship to ovarian function and endothelin-1 and nitric oxide. Regul Pept (2002) 0.77
A Case of Acute Aortic Dissection Type B Associated with Cushing's Syndrome. J Clin Med Res (2009) 0.77
Adrenomedullin increases in term asphyxiated newborns developing intraventricular hemorrhage. Clin Biochem (2004) 0.77
Lengthy follow-up after liver transplantation for nodular regenerative hyperplasia in human immunodeficiency virus-infected patients: does the disease recur? Transplantation (2013) 0.76
The level of adrenomedullin immunoreactivity in seminal fluid is higher in oligozoospermic subjects and correlates with semen biochemical parameters. Eur J Obstet Gynecol Reprod Biol (2006) 0.76
Plasma non-cholesterol sterols: a useful diagnostic tool in pediatric hypercholesterolemia. Pediatr Res (2010) 0.76
Effect of betamethasone in vivo on placental adrenomedullin in human pregnancy. J Soc Gynecol Investig (2006) 0.76
Relationship between baseline ET-1 plasma levels and outcome in patients with idiopathic pulmonary hypertension treated with bosentan. Int J Cardiol (2012) 0.75
Effect of corticosteroids and progesterone on adrenomedullin output and expression in human fetal membranes and placenta trophoblasts. Am J Obstet Gynecol (2009) 0.75
Genetic and clinical investigation of pheochromocytoma: a 22-year experience, from Freiburg, Germany to international effort. Ann N Y Acad Sci (2006) 0.75
Adrenal Pheochromocytoma Incidentally Discovered in a Patient With Parkinsonism. Medicine (Baltimore) (2015) 0.75
Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics. Regul Pept (2006) 0.75
Adrenomedullin blood concentrations in infants subjected to cardiopulmonary bypass: correlation with monitoring parameters and prediction of poor neurological outcome. Clin Chem (2007) 0.75
Response to 'Oxidative stress in patients affected by primary aldosteronism'. J Hypertens (2015) 0.75
Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease. Medicine (Baltimore) (2016) 0.75
Correction: Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects. PLoS One (2015) 0.75
[Hyponatremia in clinical practice]. Recenti Prog Med (2002) 0.75
A rare combination consisting of aldosterone-producing adenoma and adrenal myelolipoma in a patient with heterozygosity for retinoblastoma (RB) gene. J Renin Angiotensin Aldosterone Syst (2004) 0.75